1. Hong J, Lee JH. Recent advances in multiple myeloma: a Korean perspective. Korean J Intern Med. 2016; 31:820–834. PMID:
27604794.
2. Reddi DM, Lu CM, Fedoriw G, Liu YC, Wang FF, Ely S, et al. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens. Am J Clin Pathol. 2012; 138:855–866. PMID:
23161720.
3. Tang G, Zuo Z, Thomas DA, Lin P, Liu D, Hu Y, et al. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related. Haematologica. 2012; 97:919–925. PMID:
22207681.
4. Lau LG, Tan LK, Koay ES, Liu TC. Acute lymphoblastic leukemia after tandem autologous stem cell transplantations for multiple myeloma. Leukemia. 2005; 19:299–301. PMID:
15526017.
5. Piszcz J, Bolkun L, Cichocka E, Kloczko J. Secondary acute lymphoblastic leukaemia in a multiple myeloma patient. Contemp Oncol (Pozn). 2012; 16:593–595. PMID:
23788951.
6. Vardiman JW, Arber AD, et al. Therapy-related myeloid neoplasms. In : Swerdlow SH, Campo E, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press;2017. p. 241–243.
7. Lee SG, Choi JR, Kim JS, Park TS, Lee KA, Song J. Therapy-related acute lymphoblastic leukemia with t(9;22)(q34;q11.2):a case study and review of the literature. Cancer Genet Cytogenet. 2009; 191:51–54. PMID:
19389510.
8. Chen W, Wang E, Lu Y, Gaal KK, Huang Q. Therapy-related acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review. Am J Clin Pathol. 2010; 133:75–82. PMID:
20023261.